LPL Financial’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
LPL Financial's ARCT Position: Q3 2025 in Review
LPL Financial sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 10,240 shares — an estimated $133K sold.
LPL Financial first reported a position in ARCT in Q4 2020 and held it in 14 quarters. The position peaked at $451K in Q1 2024. 137 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.
- LPL Financial reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
- LPL Financial sold 10,240 Arcturus Therapeutics shares in Q3 2025, an estimated $133K.
- LPL Financial first reported a position in Arcturus Therapeutics in Q4 2020 and held it in 14 quarters.
- LPL Financial's Arcturus Therapeutics position peaked at $451K in Q1 2024.
- 137 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.
Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.